Detalles de la búsqueda
1.
Long-term health outcomes of people with reduced kidney function in the UK: A modelling study using population health data.
PLoS Med
; 17(12): e1003478, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33326459
2.
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease.
Kidney Int
; 96(1): 170-179, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31005271
3.
Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD.
Am J Kidney Dis
; 67(1): 31-9, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26385817
4.
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP).
Am J Kidney Dis
; 67(4): 576-84, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26597925
5.
The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review.
Nephrol Dial Transplant
; 31(1): 46-56, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25564537
6.
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
BMC Nephrol
; 16: 65, 2015 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25924679
7.
Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study.
Lancet Reg Health Eur
; 40: 100887, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38549731
8.
Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model.
Br J Gen Pract
; 2024 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38373851
9.
Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009-2017.
Heart
; 109(5): 388-395, 2023 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36192149
10.
Quality of care for secondary cardiovascular disease prevention in 2009-2017: population-wide cohort study of antiplatelet therapy use in Scotland.
BMJ Qual Saf
; 2023 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37775268
11.
Surveillance of infection severity: a registry study of laboratory diagnosed Clostridium difficile.
PLoS Med
; 9(7): e1001279, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22859914
12.
Increasing incidence of Escherichia coli bacteraemia is driven by an increase in antibiotic-resistant isolates: electronic database study in Oxfordshire 1999-2011.
J Antimicrob Chemother
; 67(6): 1514-24, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22438437
13.
Visualising harms in publications of randomised controlled trials: consensus and recommendations.
BMJ
; 377: e068983, 2022 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35577357
14.
Statistical models for the deterioration of kidney function in a primary care population: A retrospective database analysis.
F1000Res
; 8: 1618, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-36225973
15.
The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.
Pharmacoeconomics
; 37(11): 1305-1312, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31347104
16.
Impact of CKD on Household Income.
Kidney Int Rep
; 3(3): 610-618, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29854968
17.
A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.
Heart
; 103(23): 1880-1890, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28780579
18.
Mapping from the Parkinson's Disease Questionnaire PDQ-39 to the Generic EuroQol EQ-5D-3L: The Value of Mixture Models.
Med Decis Making
; 35(7): 902-11, 2015 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25926283
19.
Decline of meticillin-resistant Staphylococcus aureus in Oxfordshire hospitals is strain-specific and preceded infection-control intensification.
BMJ Open
; 1(1): e000160, 2011 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-22021779
Resultados
1 -
19
de 19
1
Próxima >
>>